National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Latest Drugs
Atidarsagene autotemcel (Libmeldy®). HTA ID: 21009 -
September 30, 2022
Entrectinib (Rozlytrek®). HTA ID: 22055 -
September 29, 2022
Anakinra (Kineret®). HTA ID: 22059. -
September 29, 2022
Pegvaliase (Palynziq®) HTA ID: 21057 -
September 29, 2022
Niraparib (Zejula®); 1L maintenance OVCA. HTA ID: 21004 -
September 26, 2022
Buprenorphine prolonged-release solution for injection (Buvidal®). HTA ID: 22056 -
September 23, 2022
Lenvatinib (Kisplyx®). HTA ID: 22057 -
September 22, 2022
Tucatinib (Tukysa®). HTA ID: 22058 -
September 20, 2022
Eptinezumab (Vyepti®). HTA ID: 22052 -
September 16, 2022
Rimegepant (Vydura®). HTA ID: 22051 -
September 12, 2022
1
2
3
4
5
6
7
8
9
10
...
20
30
40
...
Next Page
Last »
health check
©2022 National Centre for Pharmacoeconomics
